BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19002782)

  • 1. Molecular analysis of the multidrug transporter, P-glycoprotein.
    Germann UA; Chambers TC
    Cytotechnology; 1998 Sep; 27(1-3):31-60. PubMed ID: 19002782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the multidrug transporter.
    Germann UA
    Cytotechnology; 1993; 12(1-3):33-62. PubMed ID: 7765331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoproteins: mediators of multidrug resistance.
    Germann UA; Pastan I; Gottesman MM
    Semin Cell Biol; 1993 Feb; 4(1):63-76. PubMed ID: 8095827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic and biophysical approaches for studying the structure and function of the P-glycoprotein multidrug transporter.
    Sharom FJ; Liu R; Romsicki Y
    Biochem Cell Biol; 1998; 76(5):695-708. PubMed ID: 10353701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein.
    Kimura Y; Matsuo M; Takahashi K; Saeki T; Kioka N; Amachi T; Ueda K
    Curr Drug Metab; 2004 Feb; 5(1):1-10. PubMed ID: 14965247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and reconstitution of functional human P-glycoprotein.
    Ambudkar SV
    J Bioenerg Biomembr; 1995 Feb; 27(1):23-9. PubMed ID: 7629047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
    Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the drug binding, transport and lipid flippase activities of the p-glycoprotein multidrug transporter.
    Sharom FJ; Lugo MR; Eckford PD
    J Bioenerg Biomembr; 2005 Dec; 37(6):481-7. PubMed ID: 16691487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein and multidrug resistance.
    Gottesman MM; Pastan I; Ambudkar SV
    Curr Opin Genet Dev; 1996 Oct; 6(5):610-7. PubMed ID: 8939727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.
    Lautier D; Canitrot Y; Deeley RG; Cole SP
    Biochem Pharmacol; 1996 Oct; 52(7):967-77. PubMed ID: 8831715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
    Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
    Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
    Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
    Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein.
    Sharma S; Rose DR
    J Biol Chem; 1995 Jun; 270(23):14085-93. PubMed ID: 7775470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.